Chemotherapy Plus Monoclonal Antibody Therapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Overexpresses HER2
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- George W. Sledge, MD
Indiana University
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
45 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Pretoria Academic Hospital
Pretoria, South Africa
- Veterans Affairs Medical Center - Palo Alto
Palo Alto, California, United States
- Stanford University Medical Center
Stanford, California, United States
- Ccop - Colorado Cancer Research Program, Inc.
Denver, Colorado, United States
- H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, United States
- Emory University Hospital - Atlanta
Atlanta, Georgia, United States
- Veterans Affairs Medical Center - Atlanta (decatur)
Decatur, Georgia, United States
- Robert H. Lurie Comprehensive Cancer Center, Northwestern University
Chicago, Illinois, United States
- Veterans Affairs Medical Center - Chicago (lakeside)
Chicago, Illinois, United States
- Ccop - Central Illinois
Decatur, Illinois, United States
- Ccop - Evanston
Evanston, Illinois, United States
- Ccop - Illinois Oncology Research Association
Peoria, Illinois, United States
- Ccop - Carle Cancer Center
Urbana, Illinois, United States
- Veterans Affairs Medical Center - Indianapolis (roudebush)
Indianapolis, Indiana, United States
- Ccop - Cedar Rapids Oncology Project
Cedar Rapids, Iowa, United States
- Ccop - Wichita
Wichita, Kansas, United States
- Ccop - Ochsner
New Orleans, Louisiana, United States
- Johns Hopkins Oncology Center
Baltimore, Maryland, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- New England Medical Center Hospital
Boston, Massachusetts, United States
- Ccop - Ann Arbor Regional
Ann Arbor, Michigan, United States
- Ccop - Kalamazoo
Kalamazoo, Michigan, United States
- Mayo Clinic Cancer Center
Rochester, Minnesota, United States
- Ccop - Metro-Minnesota
Saint Louis Park, Minnesota, United States
- Ccop - Missouri Valley Cancer Consortium
Omaha, Nebraska, United States
- Trinitas Hospital - Jersey Street Campus
Elizabeth, New Jersey, United States
- Hunterdon Regional Cancer Program
Flemington, New Jersey, United States
- Ccop - Northern New Jersey
Hackensack, New Jersey, United States
- Hackensack University Medical Center
Hackensack, New Jersey, United States
- Morristown Memorial Hospital
Morristown, New Jersey, United States
- Veterans Affairs Medical Center - Albany
Albany, New York, United States
- Kaplan Cancer Center
New York, New York, United States
- Veterans Affairs Medical Center - New York
New York, New York, United States
- University of Rochester Cancer Center
Rochester, New York, United States
- Albert Einstein Comprehensive Cancer Center
The Bronx, New York, United States
- Ccop - Merit Care Hospital
Fargo, North Dakota, United States
- Ireland Cancer Center
Cleveland, Ohio, United States
- Ccop - Sooner State
Tulsa, Oklahoma, United States
- University of Pennsylvania Cancer Center
Philadelphia, Pennsylvania, United States
- Ccop - Mainline Health
Wynnewood, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 1999
- Primary completion
- 31 Jan 2007
- Completion
- 31 Mar 2009
- Last update posted
- 3 Jun 2013
- Registered enrollment
- 200
- Registry id
- NCT00003992
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.